0
Original Research: AVIAN INFLUENZA A(H5N1) |

Clinical Course of Avian Influenza A(H5N1) in Patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008

Priyanti Z. Soepandi, MD, FCCP; Erlina Burhan, MD; Hadiarto Mangunnegoro, MD, FCCP; Arifin Nawas, MD; Tjandra Yoga Aditama, MD; Lia Partakusuma, MD; Fathiyah Isbaniah, MD; Mukhtar Ikhsan, MD; Boedi Swidarmoko, MD; Agung Sutiyoso, MD; Suhud Malik, MD; Rachel Benamore, MBBChir; J. Kevin Baird, PhD; Walter R. J. Taylor, MD
Author and Funding Information

From the Rumah Sakit Persahabatan (Drs Soepandi, Burhan, Mangunnegoro, Nawas, Aditama, Partakusma, Isbaniah, Ikhsan, Swidarmoko, and Sutiyoso), Jakarta timur, Indonesia; the Center for Biomedical and Pharmaceutical R&E (Dr Malik), National Institutes of Health Research and Development, and the Eijkman-Oxford University Clinical Research Unit (Dr Baird), Jakarta, Indonesia; the Department of Radiology (Dr Benamore), Churchill Hospital, and the Nuffield Department of Clinical Medicine (Drs Baird and Taylor), University of Oxford, Oxford, England; and the Mahidol Oxford University Clinical Research Unit (Dr Taylor), Bangkok, Thailand.

Correspondence to: Erlina Burhan, MD, Rumah Sakit Persahabatan, Jalan Persahabatan raja 1, Jakarta timur, Indonesia; e-mail: eburhan@yahoo.com


Funding/Support: This study was supported by the South East Asia Infectious Disease Clinical Research Network (W. R. J. T. and J. K. B.).

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (http://www.chestpubs.org/site/misc/reprints.xhtml).


© 2010 American College of Chest Physicians


Chest. 2010;138(3):665-673. doi:10.1378/chest.09-2644
Text Size: A A A
Published online

Background:  Limited understanding of the presentation and course of influenza A(H5N1) infection in humans hinders evidence-based management.

Methods:  We reviewed the case records of patients admitted to the Persahabatan Hospital (RSP), Jakarta, Indonesia, with influenza A(H5N1) confirmed by real-time polymerase chain reaction.

Results:  Twenty-two previously well patients, aged 3 to 47 years (median 24.5 years), were identified. All attended a clinic or hospital after a median of 2 days of illness (range 0-7). Times to first dose of oseltamivir (three died before receiving oseltamivir) were 2 to 12 days (median 7 days), administered mostly (n = 15) at RSP. Nineteen patients required mechanical ventilation. Deaths numbered 18 (case fatality = 82%) occurring within hours to 6 days of RSP admission, corresponding to 6 to 16 days of illness. Admission hyperglycemia ( ≥ 140 mg/dL), unrelated to steroids or known underlying diabetes mellitus, and elevated D-dimer levels (0.81-5.2 mg/L, upper limit of normal < 0.5 mg/L) were present in 14/21 (67%) and 20/21 (95%) patients, respectively. Fibrinogen concentrations were mostly low/normal at 129.9 to 517.9 mg/dL (median 241.1, normal 200-400 mg/dL), whereas C-reactive protein (9/11) and ferritin (6/8) levels were increased. Risk factors for death (univariate analysis) included: (1) increased D-dimers, (2) hyperglycema, (3) increased urea, (4) more extensive chest radiograph shadowing, and (5) lower admission oxygen saturation.

Conclusions:  Early diagnosis and effective treatment of human influenza A(H5N1) infection remains challenging. Most patients were referred late with advanced disease. Oseltamivir had limited clinical impact. Elevated D-dimer levels, consistent with fibrinolysis, and hyperglycemia warrant more research to determine their underlying mechanisms and optimal treatment.

Figures in this Article

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543